Ganoderenic acid K
IUPAC name: (E)-6-[(3S,5R,7S,10S,12S,13R,14R,17R)-12-acetoxy-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxo-hept-5-enoic acid
CAS Number: 942950-94-9
Class: Terpenoid
Mushrooms contain this compound
1 mushrooms
| MushID |
Thai name |
Common name |
Scientific name |
Family |
| 1 |
เห็ดหลินจือ |
Lingzhi |
Ganoderma lucidum ( Curtis ) P. Karst. |
Ganodermataceae |
2D Structure
Compound Properties
SMILES
CC(=O)O[C@@H]1C(=O)C2=C([C@]3([C@@]1(C)[C@H](CC3=O)/C(=C/C(=O)CC(C(=O)O)C)/C)C)[C@@H](O)C[C@@H]1[C@]2(C)CC[C@@H](C1(C)C)O
Physicochemical Properties
| Formula |
C32H44O9 |
| Molecular wieght(g/mol) |
572.69 |
| Num. of Heavy atoms |
41 |
| Num. of Aromatic Heavy atoms |
0 |
| Fraction Csp3 |
0.72 |
| Num. of Rotatable bonds |
7 |
| Num. of H-bond acceptors |
9 |
| Num. of H-bonds donors |
3 |
| Molar Refractivity |
151.47 |
| TPSA (square Angstrom) |
155.27 |
Lipophilicity
| iLOGP |
2.59 |
| XLOGP3 |
2.38 |
| WLOGP |
3.59 |
| MLOGP |
1.72 |
| Silicos-IT LOGP |
4.49 |
| Consensus LOGP |
2.95 |
Water Solubility
| ESOL |
|
| LogS |
-4.43 |
Solubility(mg/ml) |
2.14E-02 |
Solubility(mol/l) |
3.73E-05 |
Class |
Moderately soluble |
| Ali |
|
| LogS |
-5.28 |
Solubility(mg/ml) |
2.99E-03 |
Solubility(mol/l) |
5.23E-06 |
Class |
Moderately soluble |
| Silicos-IT |
|
| LogS |
-4.38 |
Solubility(mg/ml) |
2.38E-02 |
Solubility(mol/l) |
4.15E-05 |
Class |
Moderately soluble |
Pharmacokinetics
| GI absorbtion |
Low |
| BBB permeant |
No |
| Pgp substrate |
No |
| CYP1A2 inhibitor |
No |
| CYP2C19 inhibitor |
No |
| CYP2C9 inhibitor |
No |
| CYP2D6 inhibitor |
No |
| CYP3A4 inhibitor |
Yes |
| Log Kp (skin permeation) (cm/s) |
-8.10 |
Druglikeness
| Lipinski Num. violations |
1 |
| Ghose Num. violations |
3 |
| Veber Num. violations |
1 |
| Egan Num. violations |
1 |
| Muegge Num. violations |
1 |
| Bioavailability Score |
0.11 |
Medicinal Chemistry
| PAINS Num. of alerts |
0 |
| Brenk Num. of alerts |
1 |
| Leadlikeness Num. of violations |
1 |
| Synthetic Accessibility |
6.69 |
Biological Activity
| Biological Activity |
JID |
| Anticancer |
9 |
